Table 1.
Patients’characteristics (N=131)
| Age (median) | 59.0 | (Range 25-84) |
|---|---|---|
| WHO performance status |
|
(%) |
| 0 |
37 |
(28.2) |
| 1 |
66 |
(50.4) |
| 2 |
21 |
(16.0) |
| 3 |
6 |
(4.6) |
| FIGO-stage |
|
|
| IA |
39 |
(29.8) |
| IB |
6 |
(4.6) |
| IC |
66 |
(50.4) |
| II |
20 |
(15.3) |
| Histopathology |
|
|
| Serous |
51 |
(38.9) |
| Mucinous |
20 |
(15.3) |
| Endometrioid |
42 |
(32.1) |
| Clear cell* |
16 |
(12.2) |
| Anaplastic |
2 |
(1.5) |
| FIGO-grade |
|
|
| Grade 1 |
31 |
(23.7) |
| Grade 2 |
45 |
(34.4) |
| Grade 3* | 55 | (41.9) |
Clear cell* (all clear cell tumors were graded as grade 3 tumors).